Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Sparsentan Granted Orphan Drug Designation for IgA Nephropathy Treatment
Monday, December 02, 2024Renalys Pharma has announced that sparsentan has received Orphan Drug Designation in Japan for the treatment of primary IgA nephropathy IgA nephropathy is a rare kidney condition where abnormal IgA proteins accumulate in the kidneys leading to inflam...
Everest Medicines’ New Drug Application for VELSIPITY® Accepted in Hong Kong
Monday, December 02, 2024Everest Medicines has announced the acceptance of its New Drug Application NDA for VELSIPITY etrasimod by the Department of Health of the Hong Kong Special Administrative Region
Silo Pharma Enters into Agreement with Kymanox to Develop SP-26 for Pain Management
Saturday, November 30, 2024Silo Pharma has entered a joint development agreement with Kymanox to advance the SP ketamineloaded implant SP is a ketaminebased dissolvable polymer implant developed by Silo Pharma for managing chronic pain and fibromyalgia
Everest Medicines Announces Approval of NEFECON® for IgA Nephropathy Treatment
Friday, November 29, 2024Everest Medicines today announced NEFECONs inclusion in Chinas National Reimbursement Drug List NRDL effective from January NEFECON is a patented oral delayedrelease formulation of budesonide a corticosteroid specifically designed to target the dis...
BeiGene Secures Approval for TEVIMBRA in First-Line Treatment of Advanced Oesophageal and Gastric Cancers
Thursday, November 28, 2024BeiGene has received approval from the European Commission for TEVIMBRA tislelizumab in combination with chemotherapy as a firstline treatment for advanced or metastatic oesophageal squamous cell carcinoma ESCC and gastric or gastroesophageal junctio...
Eisai and Biogen Launch LEQEMBI® (Lecanemab) for Alzheimer's Disease Treatment
Thursday, November 28, 2024Eisai and Biogen have announced the launch of LEQEMBI lecanemab a monoclonal antibody targeting amyloidbeta A aggregates in South KoreaThis follows approval by the Ministry of Food and Drug Safety MFDS in May for use in adults with mild cognitive im...
VectorBuilder and Sartorius Partner to Advance Biopharmaceutical Innovation
Wednesday, November 27, 2024VectorBuilder has entered into a strategic cooperation agreement with Sartorius This collaboration aims to enhance gene vector and mRNA bioprocess solutions facilitating the development and clinical application of cuttingedge biopharmaceutical projec...
Roche to Acquire Poseida Therapeutics, Expanding Cell Therapy Capabilities
Wednesday, November 27, 2024Roche has announced it has entered into a definitive agreement to acquire Poseida Therapeutics Poseida is known for its innovative work in developing donorderived CART cell therapies with a portfolio that includes both preclinical and clinicalstage o...
Alnylam Pharmaceuticals FDA Accepts Application for Vutrisiran to Treat ATTR Amyloidosis with Cardiomyopathy
Tuesday, November 26, 2024Alnylam Pharmaceuticals has announced that the US Food and Drug Administration FDA has accepted its supplemental New Drug Application sNDA for vutrisiran
HanAll Biopharma, Daewoong Pharmaceutical, and NurrOn Pharmaceuticals Successfully Complete Phase 1 Trial for Parkinson's Therapy
Tuesday, November 26, 2024HanAll Biopharma Daewoong Pharmaceutical and NurrOn Pharmaceuticals have successfully completed the Phase clinical trial of HL ATHA a potential diseasemodifying therapy for Parkinsons disease
